Inogen Inc (INGN) income statement
INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3068% below fair value
$5.57−0.11 (-2.02%)
Close on Nov 18, 2026Market cap $147.82MP/E –Yield –
Inogen Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 44.5%
- Operating margin
- -8.7%
- Net margin
- -6.9%
- Return on equity, FY2025
- -12.4%
Financial strength
- Current ratio
- 2.74
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 123.2%
Valuation
- P/E ratio
- –
- Price to sales
- 0.42
- Price to book
- 0.85
- Dividend yield
- –
See a number that looks wrong?